AbbVie
ABBV
S$246.21
Share price
0.43%
Change (1 day)
8.65%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Cost to borrow ABBV shares - AbbVie
Latest borrow fee for AbbVie (ABBV) shares on Interactive Brokers: 0.3959% (annualized)
Shares available to borrow: >10000000The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.
AbbVie (ABBV) - cost to borrow in the last 7 days chart
AbbVie (ABBV) - number of shares available to borrow in the last 7 days
AbbVie (ABBV) - cost to borrow from 2025 to 2023
AbbVie (ABBV) - number of shares available to borrow from 2025 to 2023
Cost to borrow for shares of similar companies or competitors
| Company | Cost to borrow (% year) | Shares available | Country |
|---|---|---|---|
 Pfizer PFE | 0.25% | 10 M | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 0.4081% | 10 M | 🇺🇸 USA |
 Eli Lilly LLY | 0.4081% | 4.4 M | 🇺🇸 USA |
 Amgen AMGN | 0.25% | 3.8 M | 🇺🇸 USA |
 Gilead Sciences GILD | 0.2891% | 10 M | 🇺🇸 USA |
 Biogen BIIB | 0.25% | 4 M | 🇺🇸 USA |
 GlaxoSmithKline GSK | 0.5034% | 0.5 M | 🇬🇧 UK |
 AstraZeneca AZN | 0.25% | 6.9 M | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | 0.4081% | 3 M | 🇺🇸 USA |